Why NRx Pharmaceuticals Stock Is Skyrocketing Today
Shares of NRx Pharmaceuticals (NASDAQ: NRXP) were skyrocketing 38.4% higher as of 3:11 p.m. EDT on Tuesday. The big jump came after the company announced two positive updates related to pipeline candidate Zyesami.
NRx said that it has submitted a revised Investigational New Drug (IND) module on the manufacturing of Zyesami to the U.S. Food and Drug Administration (FDA). This filing includes documentation confirming Nephron Pharmaceuticals is ready to supply the drug on a commercial scale. In addition, NRx stated that a European inspection at another manufacturing facility for Zyesami has been completed with "no adverse findings."
Image source: Getty Images.
Source Fool.com
